This prospective, randomized, doubleblind, placebo-controlled study evaluated the effectiveness of intraperitoneal instillation of ropivacaine in the relief of pain in patients undergoing laparoscopic appendectomy. Patients in group C (placebo control group; n = 33) received normal saline and those in group I (instillation group; n = 30) received an instillation of 2 mg/kg ropivacaine at the initiation of the pneumoperitoneum. Visual analogue scale pain scores, fentanyl consumption and the frequency at which patients pushed the button (FPB) of a patient-controlled analgesia system during the post-operative period were significantly lower in group I compared with group C, and decreased gradually with time in both groups. The total amount of fentanyl consumed and the total FPB were significantly lower in group I compared with group C. Thus, intraperitoneal ropivacaine instillation reduced pain during the post-operative period after laparoscopic appendectomy. In addition, this drug was easy to administer and had no adverse effects at the dose used.
Introduction
Laparoscopic appendectomy (LA) is now considered to be a safe and effective alternative to open appendectomy (OA). 1 -4 The introduction of LA has reduced postoperative pain and analgesia requirement compared with OA, although LA is not completely pain free. Pain after abdominal surgery is related to immobility and the difficulty associated with active coughing, which may delay discharge and result in additional complications. 5 In addition, nausea or vomiting, which stem from the use of opioids as pain killers, are factors that delay discharge. 6 Pre-emptive analgesia (i.e. the administration of drugs that modulate the development of the nociception process H Kang, B-G Kim Intraperitoneal ropivacaine and appendectomy before the pain stimuli appear) could be used to control post-operative pain, opioid consumption and the development of subsequent complications. Many clinical studies have demonstrated the inhibitory effect of pre-emptive analgesia on the development of post-traumatic hyperalgesia, resulting in the reduction of post-operative pain and of total analgesic requirements. 7 -10 Intraperitoneal instillation of local anaesthetics after laparoscopic procedures reduces post-operative pain, analgesic requirements and the stress response, and lengthens the period to first post-operative analgesic requirement. 8, 11, 12 Few studies have examined the association between the instillation of local anaesthesia and post-operative pain after LA. The aim of this prospective, randomized, double-blind, placebo-controlled study was to measure the effectiveness of this simple method of administration of ropivacaine in the relief of pain in patients undergoing LA. It was hypothesized that the requirement for analgesics to manage post-operative pain would be reduced after intraperitoneal ropivacaine instillation.
Patients and methods PATIENTS
All patients undergoing LA under general anaesthesia between March and December 2008 and who were between the ages of 18 and 65 years were candidates for inclusion in the study. Patients who weighed < 45 kg or > 100 kg, had severe underlying cardiovascular, renal or hepatic disease, or had allergy to local anaesthetics were excluded. Patients in group C (placebo control group) received normal saline and those in group I (instillation group) received instillation of 2 mg/kg ropivacaine at the initiation of the pneumoperitoneum.
The study protocol was approved by the 
STUDY DESIGN AND RANDOMIZATION
This was a randomized, double-blind, placebo-controlled study. Randomization into one of the two groups (group C or group I) was based on Excel random-number generation. The details of the series were unknown to investigators and were kept in a set of sealed envelopes, each bearing only the case number on the outside. After admission to the operating room and just before the induction of anaesthesia, the appropriate numbered envelope was opened and the card inside determined whether the patient would be in group C or group I. Two investigators blinded to the details of the study collected post-operative data. Oral intake of solid food was started as soon as patients could tolerate it and when bowel function became adequate. Patients were discharged as soon as they were adequately ingesting orally and were mobile.
GENERAL ANAESTHESIA
Anaesthesia was induced with 5 mg/kg thiopental and 0.6 mg/kg rocuronium given intravenously. The trachea was intubated and ventilation was controlled at a tidal volume of 10 ml/kg and at a respiratory rate of 10 breaths/min. Anaesthesia was maintained using 2 -3% sevoflurane and 50% nitrous oxide in oxygen. Non-invasive arterial blood pressure, electrocardiography and pulse oximetry were monitored continuously. During the surgery, patients received intravenous infusion of lactated Ringer's H Kang, B-G Kim Intraperitoneal ropivacaine and appendectomy solution at a rate of 3 -6 ml/kg per h. No additional intravenous opioids were injected.
SURGICAL TECHNIQUE
All operations were carried out by the same team of surgeons. The patient was placed in a slight Trendelenberg position. The insufflation pressure was automatically regulated and maintained at 12 -15 mmHg. The LA was performed using a two-handed, three-trocar technique. A 10-mm subumbilical port was introduced (for a 5-mm diameter telescope). Subsequently, a 5-mm port was placed in the suprapubic region and a 5-mm port was placed in the right upper quadrant. The telescope was then shifted to the right upper quadrant 5-mm port. The mesoappendix was dissected using a dissector and was divided by clipping with a Weck clip. The appendix was doubly ligated with 3-0 vicryl loop at its base and was then divided. To avoid contamination, the appendix was removed in a specimen bag. In both groups, the appendectomy site was washed at the end of the surgery with a small volume of saline (100 -200 ml) to evacuate blood, blood clots and other debridement.
PERITONEAL TOPICAL ANAESTHESIA
Ropivacaine (at a total instillation dose of 2 mg/kg) or placebo solutions were administered immediately after the creation of the pneumoperitoneum and 10 min before the beginning of surgery. The surgeon sprayed the first 50 ml of solution on the upper surface of the liver and on the right subdiaphragmatic space, to allow it to diffuse into the hepatodiaphragmatic space. The Trendelenberg position was maintained for about 2 min. After the Trendelenberg position was withdrawn, an additional 50 ml of solution was sprayed around the appendectomy site. This was performed using catheters inserted into the subumbilical and right upper quadrant trocars under direct laparoscopic control. The surgeon was not informed of the contents of the solution (ropivacaine or placebo).
POST-OPERATIVE PAIN CONTROL
To control post-operative pain, a computerized intravenous patient-controlled analgesia (PCA) system (Automed 3300 TM ; ACE Medical Corp. Ltd, Seoul, Republic of Korea) was used. Patients were continuously infused with 0.1 µg/kg per h of fentanyl and, each time pain occurred, the patients pushed the button of the PCA system, which then delivered a bolus of additional fentanyl. In the case of persistent pain > 30 mm on a visual analogue scale (VAS) of 0 -100 mm (0 mm, no pain; 100 mm, the worst possible pain), an additional 50 µg of fentanyl was injected intravenously by the nursing staff until the pain was relieved to a VAS pain score < 30 mm.
VARIABLES STUDIED
For each patient, age, gender, American Society of Anethesiologists (ASA) physical status, duration of anaesthesia (from initiation of general anaesthesia to extubation) and duration of operation (from entry of patient until removal from the operating room) were recorded.
To measure pain intensity, the VAS (0 -100 mm scale) pain score was measured by a blinded investigator at 2, 4, 8, 12, 24 and 48 h after surgery. The frequency at which patients pushed the button (FPB) of the PCA system and analgesic consumption (the sum of additional intravenous fentanyl injections and fentanyl delivered by the PCA system) were assessed at similar time points: up to 2 h, 2 -4 h, 4 -8 h, 8 -12 h, 12 -24 h and 24 -48 h.
The frequency of post-operative nausea and vomiting (PONV), which was treated by H Kang, B-G Kim Intraperitoneal ropivacaine and appendectomy intravenous delivery of 4 mg ondansetron (GlaxoSmithKline, Uxbridge, UK), and the incidence of shoulder-tip pain were noted. Furthermore, categories that represented the recovery rate were collected from each patient: these included the time to bowel movement, time to regular diet ingestion and length of hospital stay.
STATISTICAL ANALYSIS
To calculate the sample size required for this study, the VAS pain score at day 1 in a similar clinical setting was taken into account. 1 A two-tailed α error of 5% and a β error of 10% was accepted in the detection of differences of 20 mm in the VAS pain score between the two groups. Based on this calculation, the required size per group was 30 patients. Considering the anticipated compliance rate as 80%, 76 patients were asked to participate in the study.
The data are reported as mean values with variability expressed as either SD (in the tables) or SE (in the figures). Statistical analyses were performed using the SPSS ® statistical package, version 13.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . For continuous variables, a between-group comparison was performed using an unpaired t-test. Descriptive variables were analysed either by the χ 2 -test or by Fisher's exact test, as appropriate. The Pearson's correlation coefficient was used to measure the correlation between the VAS pain score and FPB, as well as between VAS pain score and total fentanyl consumption. A P-value < 0.05 was considered to be statistically significant. Figure 1 shows the trial details and patient disposition according to the CONsolidated Standards Of Reporting Trials (CONSORT) statement. 13 Among the 76 patients who were asked to participate in the study, eight H Kang, B-G Kim Intraperitoneal ropivacaine and appendectomy refused to participate and five were excluded, as they had cardiac, pulmonary or hepatic disease, morbid obesity, or allergy to anaesthetics. Among the remaining 63 patients, 33 patients were randomized to group C and 30 patients were randomized to group I. There were no significant differences between the two groups with respect to age, height, weight, ASA class, and duration of anaesthesia and operation (Table 1) .
Results
The results of the VAS pain scores are shown in Fig. 2 . There was a significant Fentanyl consumption and FPB were significantly lower in group I compared with group C at each time point during the whole observation period (Figs 3 and 4 ; P < 0.05). FPB and analgesic consumption decreased gradually in both groups over time. The total amount of fentanyl consumed and total FPB were significantly lower in group I compared with group C (Figs 5 and 6; P < 0.05). FPB and fentanyl consumption increased with increasing VAS pain score (r = 0.433, P < 0.01; and r = 0.374, P < 0.01, respectively).
There was no significant difference in the incidence of shoulder-tip pain between the two groups (Table 2) . There was a significant decrease in the incidence of nausea in group I compared with group C (P < 0.05). There was no significant difference in the incidence of vomiting between the two groups (Table  2 ). There were no significant differences regarding the time to bowel movement, duration of hospital stay and time to onset of ingestion of a regular diet between the two groups ( Table 2) . No adverse effects of intraperitoneal ropivacaine were seen in this study at the dose used.
Discussion
In this prospective study of patients who underwent LA, it was found that pre-emptive ropivacaine instillation was associated with a decreased VAS pain score, decreased need for post-operative analgesic consumption and decreased FPB compared with the placebo control. Many clinical studies on the use of intraoperative local anaesthetics have tried to assess whether this type of local anaesthesia reduces post-operative pain or the need for analgesic medication. 9,11,12, 14 -18 The results of these studies are, however, For cholecystectomy, Chundrigar et al. 14 reported that 50 mg of 0.25% bupivacaine reduced post-operative pain in 1 -2 h, but the pain was similar after 4 h. Barczynski et al. 11 showed that the instillation of 2 mg/kg bupivacaine reduced pain scores and analgesic requests during the entire study period. In contrast, Joris et al. 15 failed to show a decrease in pain after intraperitoneal delivery of 100 mg 0.125% bupivacaine.
In gynaecology, Ali et al. 16 found that intraperitoneal delivery of 100 mg 0.5% bupivacaine did not reduce pain in patients undergoing abdominal hysterectomy, whereas Narchi et al. 17 reported a decrease in pain after the administration of 100 mg 0.125% bupivacaine.
In laparoscopic gastric bypass patients, Symons et al. 18 showed no reduction of pain and analgesic consumption after administration of 75 mg 0.5% bupivacaine.
As can be seen from these reports, many studies have been performed that used intraperitoneal instillation of local anaesthetics to reduce post-operative pain after laparoscopic surgery. To our knowledge (based on a Medline search), there have been no studies on LA, and we found few articles pertaining to LA, which may be explained by the fact that pain after LA is less severe than after other laparoscopic procedures and, therefore, attracts less attention from investigators. It has been reported, however, that procedures that are commonly considered as routine, such as LA, can be rated by patients as being especially painful. 19 Moreover, the pain pattern of LA may differ from that of other laparoscopic procedures, as mentioned above for laparoscopic cholecystectomy, gynaecological surgery and gastric bypass. Most previous studies have used bupivacaine as the intraperitoneal local anaesthetic, 9,11,14 -16,18 which may be because of its long duration of action. Ropivacaine was used as the local anaesthetic in the present study because of its low toxicity combined with the fact that it has similar pharmacodynamic and pharmacokinetic properties to those reported for bupivacaine. 20 In addition, ropivacaine has vasoconstricting properties (increased 
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intraperitoneal pressure may collapse the peritoneal vessel). 19 Thus, intraperitoneal ropivacaine may be negligibly absorbed into the systemic circulation and may yield a lower plasma concentration, which has the potential to lower the frequency of cardiac and neuronal complications. Ropivacaine has, however, the potential to have severe side effects 21 and surgically dissected wounds after LA may increase the absorption of ropivacaine. Thus, the dose of ropivacaine should be as low as possible in order to avoid associated complications, but should also be sufficient to achieve adequate analgesia.
Another important issue regarding intraperitoneal instillation of drugs is the appropriate volume of medium used for instillation; 12,22 it should be large enough to reach the entire subdiaphragmatic region. Lower doses of ropivacaine and large volumes of medium yield a low concentration of ropivacaine, which will possibly fail as a surgical intraperitoneal block. Thus, it is very important to determine the right balance between a low dose of ropivacaine, sufficient volume of medium and sufficient concentration of ropivacaine to perform intraperitoneal block. The dose of ropivacaine (2 mg/kg) used in the present study was lower than that reported in the other study where ropivacaine was used safely. 12 In addition, 100 ml of medium were used, which was larger than reported in other studies describing effective intraperitoneal local anaesthetics. 14, 23 As the mean body weight was 66 kg in the present study, the mean concentration of ropivacaine used was 0.13%. Thus, it was possible to match the concentration that is commonly used in epidural analgesia. 24 The timing of the intraperitoneal administration of local anaesthetics 12,23 and the appropriate method of solution application 12,22 also seem to be of great importance. To obtain a significant preemptive effect, the intraperitoneal local anaesthetic was applied immediately after creation of the pneumoperitoneum in the present study, and the Trendelenberg position was maintained for 2 min before spraying an additional 50 ml of solution around the appendectomy site.
The PCA method is widely used for the control of post-operative pain. To assess the frequency at which patients pushed the button of the PCA system and to calculate analgesic consumption, a computerized PCA system was used in the present study. A standardized PCA solution, which contained only fentanyl as an analgesic, was also used and post-operative pain was measured by assessment of fentanyl consumption. The use of other analgesics would have limited the comparison of analgesic consumption between the two groups or the measurement of the correlation between analgesic consumption and the VAS pain score, as fentanyl and other analgesics have different potencies and properties, and can possibly interfere with each other.
There was a significant correlation between FPB and the VAS pain score and between analgesic consumption and the VAS pain score. There were significant differences in the reduction of VAS pain score, analgesic consumption and FPB in group I compared with group C for the whole period of the study (with the exception of the VAS pain score at 24 h). Thus, we propose that FPB or analgesic consumption are representative of the VAS pain score, although it is a subjective scale that is influenced by many other environmental factors.
Shoulder-tip pain secondary to diaphragmatic stretching 25 with phrenic nerve neuropraxia 26 are the main complaints of patients undergoing laparoscopic surgery.
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• Revised accepted 1 April 2010 Copyright © 2010 Field House Publishing LLP It is reasonable to suggest that ropivacaine administered in the subdiaphragmatic area blocks the nociceptive input generated in the inflamed diaphragmatic peritoneum. The incidence of shoulder-tip pain in group I was lower than that observed in group C, but this was not statistically significant. One of the reasons for non-significance may be that this was not the primary endpoint of the study; hence the optimal group size had been determined by calculating statistical power based on the VAS pain score, so the number of patients included may have been too small to reach statistical significance for shoulder-tip pain and, possibly, also for other recovery-rate categories.
Pain, gastrointestinal paralysis, nausea and vomiting can cause major problems after abdominal surgery. Anaesthetics and analgesic techniques that reduce pain, nausea and vomiting, and the lack of gastrointestinal function (ileus) may reduce the frequency of post-operative complications and decrease the length of the hospital stay. 27 Previous reports have shown that administration of intra-and post-operative epidural local anaesthetics with blockade of both nociceptive afferent and sympathetic efferent nerves may reduce pain and perioperative opioid requirements, which may lead to reduced PONV and improved bowel motility. 28 Intraoperative instillation of ropivacaine may also result in better short-term outcomes relating to post-operative bowel recovery in a similar manner. This expectation for intraoperative instillation of ropivacaine is consistent with results from the present study, particularly regarding the observation of a decrease in PONV compared with placebo, but also in terms of an earlier return of bowel function, an earlier resumption of diet and a shorter length of hospital stay although, with the exception of nausea, the differences did not reach statistical significance in the patients studied.
One limitation of the present study was that local anaesthesia was not used at the trocar site. Several studies have described pain according to the presumed mechanism: visceral or scapular pain, which can theoretically be blocked by intraperitoneal instillation; and parietal pain, which can be blocked by portside infiltration. 7, 26, 29 Secondly, although a lower amount of ropivacaine was used in the present study than in the other previous study where ropivacaine was used safely, 12 the low ropivacaine concentration in the blood makes this a safe procedure at the low dose used, and will contribute to the understanding of the pharmacokinetics of ropivacaine and its systemic effects.
In conclusion, the administration of intraperitoneal ropivacaine reduced pain during the post-operative period after LA. Moreover, it was easy to administer, had no adverse effects at this dose and has the potential to become routinely used by surgeons performing this procedure.
